Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Habib Rahbar

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
Radiology|April 21, 2012
In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parametersHabib Rahbar, Savannah C Partridge, Wendy B Demartini, et al.
Journal of the American College of Radiology : JACR|August 31, 2020
Risk for Upgrade to Malignancy After Breast Core Needle Biopsy Diagnosis of Lobular Neoplasia: A Systematic Review and Meta-AnalysisMariam N Shehata, Habib Rahbar, Meghan R Flanagan, et al.
Academic Radiology|April 21, 2020
Breast Cancer Conspicuity on Computed Versus Acquired High b-Value Diffusion-Weighted MRIMichaela R DelPriore, Debosmita Biswas, Daniel S Hippe, et al.
Radiology. Imaging Cancer|January 14, 2022
Accelerated Breast Diffusion-weighted Imaging Using Multiband Sensitivity Encoding with the CAIPIRINHA Method: Clinical Experience at 3 TDebosmita Biswas, Daniel S Hippe, Yi Wang, et al.
Radiology. Imaging Cancer|August 18, 2020
The Value of Patient and Tumor Factors in Predicting Preoperative Breast MRI OutcomesHabib Rahbar, Daniel S Hippe, Ahmed Alaa, et al.
Arxiv|November 26, 2025
Validation of Fully-Automated Deep Learning-Based Fibroglandular Tissue Segmentation for Efficient and Reliable Quantitation of Background Parenchymal Enhancement in Breast MRIYu-Tzu Kuo, Anum S Kazerouni, Vivian Y Park, et al.
Clinical Imaging|September 15, 2015
Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?Habib Rahbar, Sana Parsian, Diana L Lam, et al.
AJR. American Journal of Roentgenology|April 25, 2014
Diffusion-weighted MRI: association between patient characteristics and apparent diffusion coefficients of normal breast fibroglandular tissue at 3 TElizabeth S McDonald, Jennifer G Schopp, Sue Peacock, et al.
Radiology|May 13, 2015
Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?Brian N Dontchos, Habib Rahbar, Savannah C Partridge, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 21, 2019
Background parenchymal enhancement on breast MRI: A comprehensive reviewGeraldine J Liao, Leah C Henze Bancroft, Roberta M Strigel, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Radiology|April 21, 2012
In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parametersHabib Rahbar, Savannah C Partridge, Wendy B Demartini, et al.
Journal of the American College of Radiology : JACR|August 31, 2020
Risk for Upgrade to Malignancy After Breast Core Needle Biopsy Diagnosis of Lobular Neoplasia: A Systematic Review and Meta-AnalysisMariam N Shehata, Habib Rahbar, Meghan R Flanagan, et al.
Academic Radiology|April 21, 2020
Breast Cancer Conspicuity on Computed Versus Acquired High b-Value Diffusion-Weighted MRIMichaela R DelPriore, Debosmita Biswas, Daniel S Hippe, et al.
Radiology. Imaging Cancer|January 14, 2022
Accelerated Breast Diffusion-weighted Imaging Using Multiband Sensitivity Encoding with the CAIPIRINHA Method: Clinical Experience at 3 TDebosmita Biswas, Daniel S Hippe, Yi Wang, et al.
Radiology. Imaging Cancer|August 18, 2020
The Value of Patient and Tumor Factors in Predicting Preoperative Breast MRI OutcomesHabib Rahbar, Daniel S Hippe, Ahmed Alaa, et al.
Arxiv|November 26, 2025
Validation of Fully-Automated Deep Learning-Based Fibroglandular Tissue Segmentation for Efficient and Reliable Quantitation of Background Parenchymal Enhancement in Breast MRIYu-Tzu Kuo, Anum S Kazerouni, Vivian Y Park, et al.
Clinical Imaging|September 15, 2015
Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?Habib Rahbar, Sana Parsian, Diana L Lam, et al.
AJR. American Journal of Roentgenology|April 25, 2014
Diffusion-weighted MRI: association between patient characteristics and apparent diffusion coefficients of normal breast fibroglandular tissue at 3 TElizabeth S McDonald, Jennifer G Schopp, Sue Peacock, et al.
Radiology|May 13, 2015
Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?Brian N Dontchos, Habib Rahbar, Savannah C Partridge, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 21, 2019
Background parenchymal enhancement on breast MRI: A comprehensive reviewGeraldine J Liao, Leah C Henze Bancroft, Roberta M Strigel, et al.
Pageof 11